1. Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial. Issue 11 (November 2022) Authors: Mallory, Raburn M; Formica, Neil; Pfeiffer, Susan; Wilkinson, Bethanie; Marcheschi, Alex; Albert, Gary; McFall, Heather; Robinson, Michelle; Plested, Joyce S; Zhu, Mingzhu; Cloney-Clark, Shane; Zhou, Bin; Chau, Gordon; Robertson, Andreana; Maciejewski, Sonia; Hammond, Holly L; Baracco, Lauren; Lo... Journal: Lancet infectious diseases Issue: Volume 22:Issue 11(2022) Page Start: 1565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Viral RNA and Infectious Influenza Virus on Mobile Phones of Patients With Influenza in Hong Kong and the United States. (17th September 2021) Authors: Xiao, Jingyi; Bueno de Mesquita, P Jacob; Leung, Nancy H L; Adenaiye, Oluwasanmi; Tai, Sheldon; Frieman, Matthew B; Hong, Filbert; Chu, Daniel K W; Ip, Dennis K M; Cowling, Benjamin J; Milton, Donald K Journal: Journal of infectious diseases Issue: Volume 224:Number 10(2021) Page Start: 1730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗